Press "Enter" to skip to content

New patent for NOVO drug WEGOVY

0
Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug WEGOVY

Annual Drug Patent Expirations for WEGOVY
Annual Drug Patent Expirations for WEGOVY

Wegovy is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug.

Drug patent litigation for WEGOVY.

This drug has seventy-five patent family members in thirty-two countries.

The generic ingredient in WEGOVY is semaglutide. Two suppliers are listed for this compound. Additional details are available on the semaglutide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug WEGOVY
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions